Science Daily -
2 May 2017 22:13
In this first ever molecular drug-imaging study in children, researchers used whole-body positron emission tomography/computed tomography (PET/CT) scans to determine whether bevacizumab (Avastin) treatment of diffuse intrinsic pontine glioma (DIPG) in children is likely to be effective.
Share this Article